Kiniksa Pharmaceuticals, Ltd. (KNSA)
USD 21.4
(-2.08%)
USD 21.4
(-2.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 270.25 Million | 220.18 Million | 38.54 Million | - | - | - |
| Cost of Revenue | 56.52 Million | 46.96 Million | 9.1 Million | 3.8 Million | 3.27 Million | 286 Thousand |
| Gross Profit | 213.73 Million | 173.21 Million | 29.44 Million | -3.8 Million | -3.27 Million | -286 Thousand |
| Operating Expenses | 262.04 Million | 163.44 Million | 186.08 Million | 157.36 Million | 169.96 Million | 108.16 Million |
| Selling, General and Administrative Expenses | 129.42 Million | 97.95 Million | 85.94 Million | 45.32 Million | 34.96 Million | 21.56 Million |
| Research and Development Expenses | 76.09 Million | 65.49 Million | 99.29 Million | 112.04 Million | 135 Million | 86.59 Million |
| Other Expenses | 33.4 Million | 1.25 Million | 835 Thousand | - | - | - |
| Cost and Expenses | 295.45 Million | 210.4 Million | 195.18 Million | 157.36 Million | 169.96 Million | 108.16 Million |
| Operating Income | -25.19 Million | 7.37 Million | -156.63 Million | -157.36 Million | -169.96 Million | -108.16 Million |
| Interest Expense | - | 1.25 Million | - | - | - | - |
| Income Tax Expense | -30.73 Million | -172.33 Million | 1.38 Million | 5.15 Million | -2.04 Million | -214 Thousand |
| Earnings before Tax | -16.65 Million | 11.02 Million | -156.53 Million | -156.22 Million | -163.91 Million | -103.44 Million |
| Net Income | 14.08 Million | 183.36 Million | -157.92 Million | -161.38 Million | -161.86 Million | -103.22 Million |
| Earnings Per Share Basic | 0.20 | 2.64 | -2.30 | -2.61 | -2.99 | -3.49 |
| Earnings Per Share Diluted | 0.20 | 2.60 | -2.30 | -2.61 | -2.99 | -3.49 |
| Weighted Average Shares Outstanding | 70.05 Million | 69.38 Million | 68.57 Million | 61.84 Million | 54.04 Million | 29.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 71.92 Million | 70.42 Million | 68.57 Million | 61.84 Million | 54.04 Million | 29.54 Million |
| Gross Margin | 0.79 | 0.79 | 0.76 | - | - | - |
| EBIT Margin | -0.08 | 0.04 | -4.06 | - | - | - |
| Profit Margin | 0.05 | 0.83 | -4.10 | - | - | - |
| EBITDA | -22.85 Million | 9.77 Million | -154.28 Million | -152.42 Million | -167.89 Million | -107.87 Million |
| Earnings Before Tax Margin | -0.09 | 0.03 | -4.06 | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 112.21 Million | 108.63 Million | 79.85 Million | 270.25 Million | 83.39 Million | 67.04 Million |
| Cost of Revenue | 49.41 Million | 42.45 Million | 31.53 Million | 91.04 Million | 26.75 Million | 26.39 Million |
| Gross Profit | 62.79 Million | 66.17 Million | 48.32 Million | 179.21 Million | 56.63 Million | 40.64 Million |
| Operating Expenses | 72.45 Million | 66.29 Million | 64.86 Million | 204.41 Million | 56.55 Million | 51.57 Million |
| Selling, General and Administrative Expenses | 46.39 Million | 42.39 Million | 38.68 Million | - | 36.73 Million | 34.46 Million |
| Research and Development Expenses | 26.05 Million | 23.89 Million | 26.18 Million | - | 19.81 Million | 17.1 Million |
| Other Expenses | 20.1 Million | 2.42 Million | 2.26 Million | 8.54 Million | 2.36 Million | 2.42 Million |
| Cost and Expenses | 121.87 Million | 108.74 Million | 96.4 Million | 295.45 Million | 83.31 Million | 77.97 Million |
| Operating Income | -9.65 Million | -117 Thousand | -16.54 Million | -25.19 Million | 81 Thousand | -10.92 Million |
| Interest Expense | - | - | - | - | 1.83 Million | - |
| Income Tax Expense | 5.49 Million | 6.21 Million | 3.42 Million | -30.73 Million | -22.78 Million | 5.35 Million |
| Earnings before Tax | -7.2 Million | 2.3 Million | -14.27 Million | -16.65 Million | 2.45 Million | -8.49 Million |
| Net Income | -12.69 Million | -3.9 Million | -17.7 Million | 14.08 Million | 25.23 Million | -13.85 Million |
| Earnings Per Share Basic | -0.18 | -0.06 | -0.25 | - | 0.36 | -0.20 |
| Earnings Per Share Diluted | -0.18 | -0.06 | -0.25 | - | 0.35 | -0.20 |
| Weighted Average Shares Outstanding | 71.72 Million | 71 Million | 70.63 Million | 70.05 Million | 70.37 Million | 70.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 71.72 Million | 71 Million | 70.63 Million | 71.92 Million | 72.66 Million | 70.18 Million |
| Gross Margin | 0.56 | 0.61 | 0.61 | 0.66 | 0.68 | 0.61 |
| EBIT Margin | -0.08 | 0.00 | -0.20 | - | 0.00 | -0.16 |
| Profit Margin | -0.11 | -0.04 | -0.22 | 0.05 | 0.30 | -0.21 |
| EBITDA | -9.25 Million | 313 Thousand | -16.07 Million | - | 317 Thousand | -10.92 Million |
| Earnings Before Tax Margin | -0.09 | -0.00 | -0.21 | -0.09 | 0.00 | -0.16 |
ALDRV
ENGINERSIN
5471
BMEA
RRX
TRT